CFDB - Cystic Fibrosis DataBase

ongoing trials trial from

PPIs and Fat Absorption in CF and EPI - Phase 2 - Recruiting

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment


Pancreatic Insufficiency|Cystic Fibrosis - 12 Years and older   (Child, Adult, Older Adult)


Drug: Omeprazole 40 MG|Drug: Placebo oral capsule

Outcome measures

Coefficient of fat absorption|Duodenal pH|Fat absorption via Malabsorption Blood Test

Keywords: Adolescent; Child; Drug Administration Schedule; Gastrointestinal Agents; Gastrointestinal Diseases; non pharmacological intervention - devices OR physiotherapy; pharmacological_intervention; Omeprazole; Pancreas insufficiency; Pancreatic Diseases; Pancreatic Enzyme Replacement Therapy; Proton pump inhibitors; Malabsorption; Nutrition Disorders; High-Dose;